N-(m-PEG4)-N'-(Biotin-PEG2-amido-PEG4)-Cy5
Code | Size | Price |
---|
TAR-T18426-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T18426-500mg | 500mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Images
Documents
Further Information
Bioactivity:
N-(m-PEG4)-N'-(Biotin-PEG2-amido-PEG4)-Cy5 is a polyethylene glycol (PEG) derived linker commonly utilized in PROTAC synthesis[1].
CAS:
2107273-78-7
Molecular Weight:
1185.95
Purity:
0.98
SMILES:
[Cl-].[H][C@]12CS[C@@H](CCCCC(=O)NCCOCCOCCNC(=O)CCOCCOCCOCCOCCN3C(=CC=CC=CC4=[N+](CCOCCOCCOCCOC)c5ccccc5C4(C)C)C(C)(C)c4ccccc34)[C@@]1([H])NC(=O)N2 |w:40.39,42.41,44.43,c:44|
References
An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.